As one of the world’s leading independent biomedical research institutions, Texas Biomedical Research Institute is dedicated to advancing the health of our global community through innovative biomedical research.
Principal Investigator(s)
Hammargren, Mark
Acquisition and deployment of the CrimeEye video surveillance system with Genetec video analytics that will allow our security team to maximize their efforts to keep our campus secure by having better situational awareness through enhanced monitoring, verification and validation of threats improving security response times.
As one of the world’s leading independent biomedical research institutions, Texas Biomedical Research Institute is dedicated to advancing the health of our global community through innovative biomedical research.
Principal Investigator(s)
Shtanko, Olena
Funded by
Emergence Venture Partners, LLC
The goal is to have immediate impact by identifying prophylactic/therapeutic interventions using micronutrients as effective, low-cost, low-risk countermeasures to reduce viral damage to human airway cells and mitigate virus spread during this pandemic. The impact of our focus on ?epithelial defense? will provide an immediate means to fortify airway epithelial barrier function early during SARS-CoV-2 illness, which will reduce lung water accumulation and dyspnea in infected patients.
As one of the world’s leading independent biomedical research institutions, Texas Biomedical Research Institute is dedicated to advancing the health of our global community through innovative biomedical research.
Principal Investigator(s)
Turner, Joanne
Funded by
National Institutes of Health
The major goal of the project is to understand COVID-19 in the elderly for the development of cures or vaccines.
As one of the world’s leading independent biomedical research institutions, Texas Biomedical Research Institute is dedicated to advancing the health of our global community through innovative biomedical research.
Principal Investigator(s)
Giavedoni, Luis D.
Funded by
Janssen Pharmaceuticals, Inc.
This project is a pilot study to demonstrate that ELISPOT assays are performing adequately.
As one of the world’s leading independent biomedical research institutions, Texas Biomedical Research Institute is dedicated to advancing the health of our global community through innovative biomedical research.
Principal Investigator(s)
Shtanko, Olena
Funded by
Wellcome Trust
Collaborating Institutions
Intervir RX
For this proposal, we will assess three compounds for antiviral activity in a cell-based Lassa virus infection assay.
As one of the world’s leading independent biomedical research institutions, Texas Biomedical Research Institute is dedicated to advancing the health of our global community through innovative biomedical research.
Principal Investigator(s)
Torrelles, Jordi B
Funded by
National Institutes of Health
Collaborating Institutions
Triterpenoid Therapeutics Inc
For this proposal, we will be responsible for the experiments involving infection of K18 hACE2 mice with SARS-CoV-2 USA-WA1/2020 strain and assess the effectivity of a drug compound provided by the partnering company.
As one of the world’s leading independent biomedical research institutions, Texas Biomedical Research Institute is dedicated to advancing the health of our global community through innovative biomedical research.
Principal Investigator(s)
Kaushal, Deepak
Funded by
National Institutes of Health
This major goal of this funding is to outfit the Pathology Unit of SNPRC with a new chemistry analyzer, a new slide stainer and coverslipper, as well as seeks to purchase a state of the art whole slide scanner, which will provide a significant upgrade to research capabilities supported by Texas Biomed.
As one of the world’s leading independent biomedical research institutions, Texas Biomedical Research Institute is dedicated to advancing the health of our global community through innovative biomedical research.
Principal Investigator(s)
Giavedoni, Luis D.
Funded by
Janssen Pharmaceuticals, Inc.
The major goal of this study is to evaluate the cellular immune response in macaques vaccinated with an anti-heme vaccine.
